This text is translated into Russian by google automatic human level neural machine.
EastRussia is not responsible for any mistakes in the translated text. Sorry for the inconvinience.
Please refer to the text in Russian as a source.
Interferon-based COVID medicine is being created in Novosibirsk
An interferon-based drug for COVID-19 is being created by scientists from Novosibirsk. For people, this medicine will appear by the fall of next year. While there are animal tests.
This was announced by the director of the research and production association "SibBioVet" Alexander Spitsyn at the OpenBio conference. He said that last year the company released the antiviral veterinary drug Vitalang 2 based on high-polymer RNA, which is widely used in Russia. Now SibBioVet is creating a cure for coronavirus for people based on it. Spitsyn specified that the new drug will have a wide spectrum of action and a variety of methods of administration - drops, inhalation, vaccine.
The scientist explained that when the drug enters the cell quickly, interferon begins to actively enter it. After exposure, the drug breaks down into particles that are safe for the body and participates in biochemical processes. Spitsyn said about the safety of the drug and the possibility of its use for different age groups in the future.
Sergei Netesov, the head of the bionanotechnology laboratory at Novosibirsk State University, warned that the drug being developed cannot be taken for a long time: exposure to large amounts of interferon causes a side effect - depression.